LRRC8E Inhibitors
Chemical compounds that indirectly inhibit the activity of LRRC8E often target ion channels and transporters that are essential for maintaining the ionic balance and membrane potential within cells. Amiloride, for example, diminishes sodium reabsorption through its inhibition of ENaC, which is likely to impact LRRC8E activity as it could disrupt the sodium gradient and membrane depolarization events that participate in the regulation of LRRC8E.
Similarly, niflumic acid and flufenamic acid, both chloride channel blockers, would inhibit LRRC8E by altering chloride ion flux. This change in anion transport would directly affect cellular processes such as volume regulation and signal transduction, which are hypothesized to be regulated by LRRC8E. Gadolinium chloride's blockade of certain ion channels could also lead to an indirect reduction in LRRC8E activity by perturbing the ion flow and associated signaling pathways that are fundamental for LRRC8E
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
A potassium-sparing diuretic that blocks epithelial sodium channels (ENaC). Inhibition of ENaC can indirectly inhibit LRRC8E if LRRC8E is functionally coupled with sodium transport processes, leading to altered ion homeostasis and cell volume regulation, which are essential for LRRC8E function. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $153.00 $357.00 | 4 | |
A lanthanide compound known to block certain types of ion channels. If LRRC8E is associated with or regulated by these channels' activity, gadolinium can indirectly inhibit LRRC8E by disrupting ion flow and the associated signaling pathways, potentially affecting the volume-regulated anion channels (VRAC). | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
An estrogen receptor modulator that can alter calcium homeostasis. Since calcium signaling can modulate the activity of volume-sensitive ion channels, tamoxifen may indirectly inhibit LRRC8E by affecting calcium-dependent signaling pathways linked to cell volume control where LRRC8E might be implicated. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
A nonsteroidal anti-inflammatory drug that blocks chloride channels. If LRRC8E's activity is dependent on chloride conductance, the inhibition of these channels by niflumic acid could lead to an indirect inhibition of LRRC8E by altering ion homeostasis and signaling. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
An inhibitor of chloride channels. LRRC8E function could be indirectly inhibited by IAA-94 if it is involved in chloride ion transport, as this would disrupt the ionic balance and signaling pathways necessary for the proper functioning of LRRC8E. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
A member of the fenamate group of nonsteroidal anti-inflammatory drugs that blocks chloride channels. Similar to niflumic acid, flufenamic acid can indirectly inhibit LRRC8E activity by altering chloride ion transport and membrane potential, processes that could be essential for LRRC8E function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil can indirectly inhibit LRRC8E by altering calcium-dependent signaling pathways, which could be necessary for the regulation and function of LRRC8E, especially if LRRC8E is implicated in calcium-sensitive cellular processes. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
An alkaloid that acts as a potassium channel blocker. If LRRC8E is functionally interconnected with potassium channels, the inhibition of these channels by quinine could indirectly result in the inhibition of LRRC8E by modifying the electrical properties of cells and intracellular signaling. | ||||||
Carbenoxolone | 5697-56-3 | sc-507294 | 1 g | $50.00 | ||
A derivative of glycyrrhetinic acid that inhibits gap junction communication. LRRC8E could be indirectly inhibited by carbenoxolone if its function is related to intercellular communication via gap junctions, as this would affect the signaling environment critical for LRRC8E's role in the cell. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
A calcium channel blocker with additional potassium channel blocking activity. By altering both calcium and potassium channel activities, bepridil could indirectly inhibit LRRC8E if its function is tied to the signaling pathways affected by these ions, impacting cellular processes such as volume regulation. | ||||||